SRCIN1 and neoplasm: In this study, we present evidence that, by its ability to interact with and inhibit β-Catenin, p140Cap can orchestrate an anti-tumor immune response, influencing the composition of the TME immune infiltrate to prevent the establishment of a tumor conducive immune environment.